文献速递其他结缔组织病

内皮细胞对I型干扰素的反应参与系统性硬化症血管病变与纤维化并预测疾病进展

Endothelial Response to Type I Interferon Contributes to Vasculopathy and Fibrosis and Predicts Disease Progression of Systemic Sclerosis.
PubMed 文献 · Arthritis Rheumatol · 2024-01-01

该研究通过对皮肤活检进行单细胞RNA测序发现,内皮细胞的I型干扰素特征在系统性硬化症患者中增强,且在弥漫型皮肤型中高于局限型皮肤型、高于健康对照;血管MX1预测疾病进展的表现与皮肤评分相当,在弥漫型皮肤型亚组中更优。

要点

  • 内皮细胞I型干扰素特征在系统性硬化症患者中增强,弥漫型皮肤型高于局限型皮肤型,后者高于健康对照。
  • 内皮间质转化评分与内皮细胞I型干扰素特征平行升高。
  • 基线血管MX1预测6至34个月疾病进展的表现与皮肤评分相当,在弥漫型皮肤型亚组中更优。

核心结论

  • 内皮细胞I型干扰素特征可区分系统性硬化症皮肤亚型和疾病进展,并可能参与血管病变和纤维化。

研究设计与样本

  • 对4例系统性硬化症患者和2例对照的皮肤活检进行单细胞RNA测序。
  • 两个公开皮肤单细胞RNA测序数据集用于验证:GSE138669含12例弥漫型皮肤型系统性硬化症和10例对照,GSE195452含52例弥漫型皮肤型、41例局限型皮肤型系统性硬化症和54例对照。
  • 在博来霉素联合IFNα-2腺相关病毒诱导模型中功能研究,并在61例系统性硬化症队列中验证。

主要发现

  • 发现与验证数据集结果相似:内皮细胞在皮肤非免疫细胞中I型干扰素特征最突出。
  • 内皮细胞I型干扰素特征在系统性硬化症患者较对照增高,在弥漫型皮肤型较局限型皮肤型增高。
  • 毛细血管内皮细胞I型干扰素特征在弥漫型皮肤型高于局限型皮肤型、高于健康对照,内皮间质转化评分平行升高。
  • 血管MX1在系统性硬化症较健康对照皮肤、弥漫型皮肤型较局限型皮肤型皮肤均显著升高。
  • 基线血管MX1预测6至34个月疾病进展的表现与皮肤评分相当,在弥漫型皮肤型亚组中更优。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Interferon (IFN)-1 signatures are a hallmark of patients with systemic sclerosis (SSc). However, its significance in clinical stratification and contribution to deterioration still need to be better understood. METHODS: For hypothesis generation, we performed single-cell RNA sequencing (scRNA-seq) on skin biopsies (four patients with SSc and two controls) using the BD Rhapsody platform. Two publicly available data sets of skin scRNA-seq were used for validation (GSE138669: 12 patients with diffuse cutaneous SSc [dcSSc] and 10 controls; GSE195452: 52 patients with dcSSc and 41 patients with limited cutaneous SSc [lcSSc] and 54 controls). The IFN-1 signature was mapped, functionally investigated in a bleomycin plus IFNα-2 adenovirus-associated virus (AAV)-induced model and verified in an SSc cohort (n = 61). RESULTS: The discovery and validation data sets showed similar findings. Endothelial cells (ECs) had the most prominent IFN-1 signature among dermal nonimmune cells. The EC IFN-1 signature was increased both in patients with SSc versus controls and in patients with dcSSc versus those with lcSSc. Among EC subclusters, the IFN-1 signature was statistically higher in the capillary ECs of patients with dcSSc, which was higher than those in patients with lcSSc, which in turn was higher than those in healthy controls (HCs). Endothelial-to-mesenchymal transition (EndoMT) scores increased in parallel. Deteriorated bleomycin-induced dermal fibrosis, EndoMT, and perivascular fibrosis and caused blood vessel loss with EC apoptosis. Vascular myxovirus resistance (MX) 1, an IFN-1 response protein, was significantly increased both in total SSc versus HC skin and in dcSSc versus lcSSc skin. Baseline vascular MX1 performed similarly to skin score in predicting disease progression over 6 to 34 months in total SSc and was superior in the dcSSc subpopulation. CONCLUSION: The EC IFN-1 signature distinguished SSc skin subtypes and disease progression and may contribute to vasculopathy and fibrosis.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Yin H, Distler O, Shen L, et al. Endothelial Response to Type I Interferon Contributes to Vasculopathy and Fibrosis and Predicts Disease Progression of Systemic Sclerosis. Arthritis Rheumatol. 2024. PMID: 37488975. doi:10.1002/art.42662

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。